Alexey A. Matskevich
Directeur Technique/Scientifique/R&D chez TheraMAB LLC
Profil
Alexey A.
Matskevich is currently the Chief Scientific Officer at TheraMAB LLC.
Prior to this, he worked as a Senior Research Associate at the University of Zurich, the University of Lausanne, and the University of Strasbourg.
He received his graduate and doctorate degrees from Moscow State University Lomonosov.
Postes actifs de Alexey A. Matskevich
| Sociétés | Poste | Début |
|---|---|---|
TheraMAB LLC
 TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Alexey A. Matskevich
| Sociétés | Poste | Fin |
|---|---|---|
| University of Lausanne | Corporate Officer/Principal | 01/01/2009 |
| University of Zurich | Corporate Officer/Principal | 01/01/2008 |
| University of Strasbourg | Corporate Officer/Principal | 01/01/2005 |
Formation de Alexey A. Matskevich
| Moscow State University Lomonosov | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
TheraMAB LLC
TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Health Technology |
